Delivery Order SPE2DB22D2007-SPE2DB24FJ1GL
Award Date 4/5/24
Potential Completion Date 4/8/24
Potential Value $5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $60,934.22 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Dupixent 300 mg/2 ml pens. This contract has an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,853.26 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the procurement of Dupixent 300 mg/2 ml pens and has an ultimate completion date of March 14, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which was issued under a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that runs through...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp., a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen. The contract has a firm fixed price of $4,502.20 and a completion date of April 16, 2024. Amerisourcebergen Drug Corp. has an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle for the company...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $9,914.10 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Dupixent 300 mg/2 ml pens. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by DLA to AmerisourceBergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $4,957.05 firm fixed price delivery order contract for the supply of Dupixent 300 mg/2 ml pen 2 ml. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to provide pharmaceutical products and medical supplies to military treatment programs and facilities...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml pens. The $25,339.82 firm-fixed-price contract has an ultimate completion date of August 19, 2022. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $7,634.54 contract is for the supply of the specialty pharmaceutical product Dupixent 300 mg/2 ml pen. The delivery order has an ultimate completion date of March 27, 2024. Amerisourcebergen Drug Corp also holds a single-award indefinite delivery contract (IDC) with...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $12,507.37 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. This order is for the supply of the specialty pharmaceutical product Dupixent 300 mg/2 ml pen, with an ultimate completion date of March 19, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order (SPE2DX15D1053|SPE2DX24F6KHK) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Dupixent 200 mg/1.14 ml pen. The delivery order, valued at $2,703.29, has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on an indefinite delivery contract (IDC)...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Dupixent 300 mg/2 ml pens. The contract has a ceiling value of $6,887.48 and a period of performance through March 18, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp with a potential value of up to $999,999,999.00...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ1GLDelivery Order
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm-fixed-price delivery order contract worth $4,957.05 for the supply of Dupixent 300 mg/2 ml pens. The contract has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order does not have a set-aside designation.
Generated 7/5/24, 9:12 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 4/5/24 |